10-93519749-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018131.5(CEP55):​c.1133A>T​(p.His378Leu) variant causes a missense change. The variant allele was found at a frequency of 0.73 in 1,613,748 control chromosomes in the GnomAD database, including 439,066 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 33484 hom., cov: 33)
Exomes 𝑓: 0.74 ( 405582 hom. )

Consequence

CEP55
NM_018131.5 missense

Scores

1
6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.13

Publications

43 publications found
Variant links:
Genes affected
CEP55 (HGNC:1161): (centrosomal protein 55) Enables identical protein binding activity. Involved in cranial skeletal system development; establishment of protein localization; and midbody abscission. Acts upstream of or within mitotic cytokinesis. Located in Flemming body; centriolar satellite; and plasma membrane. Implicated in multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly. [provided by Alliance of Genome Resources, Apr 2022]
CEP55 Gene-Disease associations (from GenCC):
  • multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.6668961E-6).
BP6
Variant 10-93519749-A-T is Benign according to our data. Variant chr10-93519749-A-T is described in ClinVar as Benign. ClinVar VariationId is 1209684.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.761 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP55NM_018131.5 linkc.1133A>T p.His378Leu missense_variant Exon 8 of 9 ENST00000371485.8 NP_060601.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP55ENST00000371485.8 linkc.1133A>T p.His378Leu missense_variant Exon 8 of 9 1 NM_018131.5 ENSP00000360540.3
CEP55ENST00000496302.1 linkn.182A>T non_coding_transcript_exon_variant Exon 3 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.633
AC:
96234
AN:
151984
Hom.:
33467
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.322
Gnomad AMI
AF:
0.691
Gnomad AMR
AF:
0.732
Gnomad ASJ
AF:
0.761
Gnomad EAS
AF:
0.567
Gnomad SAS
AF:
0.678
Gnomad FIN
AF:
0.807
Gnomad MID
AF:
0.693
Gnomad NFE
AF:
0.766
Gnomad OTH
AF:
0.687
GnomAD2 exomes
AF:
0.714
AC:
179525
AN:
251300
AF XY:
0.722
show subpopulations
Gnomad AFR exome
AF:
0.316
Gnomad AMR exome
AF:
0.757
Gnomad ASJ exome
AF:
0.761
Gnomad EAS exome
AF:
0.573
Gnomad FIN exome
AF:
0.799
Gnomad NFE exome
AF:
0.766
Gnomad OTH exome
AF:
0.737
GnomAD4 exome
AF:
0.740
AC:
1082179
AN:
1461646
Hom.:
405582
Cov.:
44
AF XY:
0.741
AC XY:
538712
AN XY:
727154
show subpopulations
African (AFR)
AF:
0.301
AC:
10060
AN:
33476
American (AMR)
AF:
0.753
AC:
33690
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.761
AC:
19895
AN:
26132
East Asian (EAS)
AF:
0.556
AC:
22074
AN:
39690
South Asian (SAS)
AF:
0.693
AC:
59768
AN:
86256
European-Finnish (FIN)
AF:
0.798
AC:
42581
AN:
53384
Middle Eastern (MID)
AF:
0.714
AC:
4113
AN:
5764
European-Non Finnish (NFE)
AF:
0.762
AC:
847054
AN:
1111838
Other (OTH)
AF:
0.711
AC:
42944
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
14070
28139
42209
56278
70348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20232
40464
60696
80928
101160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.633
AC:
96262
AN:
152102
Hom.:
33484
Cov.:
33
AF XY:
0.637
AC XY:
47354
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.321
AC:
13324
AN:
41476
American (AMR)
AF:
0.732
AC:
11204
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.761
AC:
2641
AN:
3470
East Asian (EAS)
AF:
0.566
AC:
2917
AN:
5150
South Asian (SAS)
AF:
0.677
AC:
3263
AN:
4818
European-Finnish (FIN)
AF:
0.807
AC:
8540
AN:
10584
Middle Eastern (MID)
AF:
0.684
AC:
201
AN:
294
European-Non Finnish (NFE)
AF:
0.766
AC:
52085
AN:
67988
Other (OTH)
AF:
0.690
AC:
1458
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1519
3038
4556
6075
7594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.738
Hom.:
29441
Bravo
AF:
0.610
TwinsUK
AF:
0.761
AC:
2822
ALSPAC
AF:
0.769
AC:
2964
ESP6500AA
AF:
0.328
AC:
1443
ESP6500EA
AF:
0.755
AC:
6494
ExAC
AF:
0.703
AC:
85369
Asia WGS
AF:
0.635
AC:
2208
AN:
3478
EpiCase
AF:
0.761
EpiControl
AF:
0.767

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CEP55-related disorder Benign:1
Oct 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.039
T
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.73
T
MetaRNN
Benign
0.0000017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
6.1
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-2.5
N
REVEL
Benign
0.081
Sift
Benign
0.089
T
Sift4G
Uncertain
0.050
T
Polyphen
0.48
P
Vest4
0.18
MPC
0.25
ClinPred
0.026
T
GERP RS
5.8
Varity_R
0.099
gMVP
0.34
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293277; hg19: chr10-95279506; COSMIC: COSV65184775; COSMIC: COSV65184775; API